Search

Most of the therapeutic systems developed for managing chronic skin wounds lack adequate mechanical and hydration properties, primarily because they rely on a single component. This study addresses this issue by combining organic and inorganic materials to obtain hybrid films with enhanced mechanical behavior, adhesion, and fluid absorption properties. To that aim, chitosan/hydrolyzed collagen blends were mixed with halloysite/antimicrobial nanohybrids at 10% and 20% (w/w) using glycerin or glycerin/polyethylene glycol-1500 as plasticizers. The films were characterized through the use of Fourier-transform infrared (FTIR) spectroscopy, thermogravimetric analysis (TGA), and electron microscopy. The mechanical properties were evaluated macroscopically using tensile tests, and at a nanoscale through atomic force microscopy (AFM) and nanoindentation. Thermodynamic studies were conducted to assess their hydrophilic or hydrophobic character. Additionally, in vitro cytocompatibility tests were performed on human keratinocytes. Results from FTIR, TGA, AFM and electron microscopy confirmed the hybrid nature of the films. Both tensile tests and nanomechanical measurements postulated that the nanohybrids improved the films' toughness and adhesion and optimized the nanoindentation properties. All nanohybrid-loaded films were hydrophilic and non-cytotoxic, showcasing their potential for skin wound applications given their enhanced performance at the macro- and nanoscale. [ABSTRACT FROM AUTHOR]

In this research, the shuttle effect and the low sulfur activation of lithium–sulfur batteries were mitigated by coating the cathode side of Celgard 2400 separators with mixtures of carbon black/chitosan or carbon black/polyvinylidene fluoride using the simple slurry technique. Carbon nanoparticles and the polar groups of the polymers were responsible for boosting the reaction kinetics of sulfur and the chemical and physical trapping of lithium polysulfides. The adsorption of sulfur species in the coated separators was confirmed by the morphologic changes observed in the AFM and SEM images and by the new elements presented in the EDX spectra after 100 charge/discharge cycles. The high intensity of the peaks in the cyclic voltammograms and the long plateaus in the discharge profiles support the improvement in the reaction kinetics. The batteries with the carbon black/chitosan- and carbon black/polyvinylidene fluoride-coated separators reached high specific discharge capacities of 833 and 698 mAhg−1, respectively, after 100 cycles at 0.5 C. This is promising for this kind of technology, and detailed results are presented in the article. [ABSTRACT FROM AUTHOR]

The development of anticancer drug delivery systems based on biodegradable nanoparticles has been intended to maximize the localization of chemotherapy agents within tumor interstitium, along with negligible drug distribution into healthy tissues. Interestingly, passive and active drug targeting strategies to cancer have led to improved nanomedicines with great tumor specificity and efficient chemotherapy effect. One of the most promising areas in the formulation of such nanoplatforms is the engineering of magnetically responsive nanoparticles. In this way, we have followed a chemical modification method for the synthesis of magnetite/chitosan- l-glutamic acid (core/shell) nanostructures. These magnetic nanocomposites (average size ≈340 nm) exhibited multifunctional properties based on its capability to load the antitumor drug doxorubicin (along with an adequate sustained release) and its potential for hyperthermia applications. Compared to drug surface adsorption, doxorubicin entrapment into the nanocomposites matrix yielded a higher drug loading and a slower drug release profile. Heating characteristics of the magnetic nanocomposites were investigated in a high-frequency alternating magnetic gradient: a stable maximum temperature of 46 °C was successfully achieved within 40 min. To our knowledge, this is the first time that such kind of stimuli-sensitive nanoformulation with very important properties (i.e., magnetic targeting capabilities, hyperthermia, high drug loading, and little burst drug release) has been formulated for combined antitumor therapy against cancer. [ABSTRACT FROM AUTHOR]

Background: Despite the very efficient antitumor activity of conventional chemotherapy, generally high doses of anticancer molecules must be administered to obtain the required therapeutic action, simultaneously leading to severe side effects. This is frequently a consequence of the development of multidrug resistance by cancer cells and of the poor pharmacokinetic profile of these agents. Objective: In Order to improve the antitumor effect of tegafur and overcome their important drawbacks, we have investigated its incorporation into a drug nanoplatform based on the biodegradable polymer chitosan. Materials and Methods: Two tegafur loading methods were studied: (i) absorption into the polymeric network (entrapment procedure); and (ii) surface deposition (adsorption procedure) in already formed chitosan nanoparticles. Results: Tegafur entrapment into the polymeric matrix has yielded higher drug loading values and a slower drug release profile, compared to single surface adsorption. The main factores determining the drug loading to chitosan were identified. Discussion and Conclusion: Such polymeric colloid present very interesting properties for efficient tegafur delivery to cancer. [ABSTRACT FROM AUTHOR]

A (core/shell)/shell nanostructure (production performance ≈ 50%, mean diameter ≈ 330 nm) was built using maghemite, PLGA, and chitosan. An extensive characterization proved the complete inclusion of the maghemite nuclei into the PLGA matrix (by nanoprecipitation solvent evaporation) and the disposition of the chitosan shell onto the nanocomposite (by coacervation). Short-term stability and the adequate magnetism of the nanocomposites were demonstrated by size and electrokinetic determinations, and by defining the first magnetization curve and the responsiveness of the colloid to a permanent magnet, respectively. Safety of the nanoparticles was postulated when considering the results from blood compatibility studies, and toxicity assays against human colonic CCD-18 fibroblasts and colon carcinoma T-84 cells. Cisplatin incorporation to the PLGA matrix generated appropriate loading values (≈15%), and a dual pH- and heat (hyperthermia)-responsive drug release behaviour (≈4.7-fold faster release at pH 5.0 and 45 °C compared to pH 7.4 and 37 °C). The half maximal inhibitory concentration of the cisplatin-loaded nanoparticles against human lung adenocarcinoma A-549 cells was ≈1.6-fold less than that of the free chemotherapeutic. Such a biocompatible and tri-stimuli responsive (maghemite/PLGA)/chitosan nanostructure may found a promising use for the effective treatment of lung cancer. [ABSTRACT FROM AUTHOR]

[Display omitted] • Reproducible formulation of magnetoparticles with potential in antitumor magnetic hyperthermia. • Extensive characterization of the (core/shell)/shell nanostructure, including the magnetic responsiveness. • The capabilities for magnetic hyperthermia agents were demonstrated even at low field strength. • The ex vivo hemocompatibility evaluation provided a valid proof of concept for the non-toxic and safe profile of the magnetite/poly(ε -caprolactone))/chitosan nanoparticles. Magnetic (core/shell)/shell nanoparticles are promising tools for biomedical applications based on hyperthermia. In this work, magnetite particles were obtained by chemical coprecipitation and were used in the preparation of a (magnetite/poly(ε -caprolactone)/chitosan nanocomposite. That (core/shell)/shell nanostructure was characterized by electron microscopy, energy-dispersive X-ray spectroscopy, electrophoresis, thermogravimetric analysis, and X-ray diffraction spectroscopy. The effect on the heating efficiency of the nanocomposite at different magnetic field strengths were investigated finding that, even at low field strengths, the hyperthermia range was reached rapidly. Negligible toxicity of the particles was postulated given their null effect on blood components. These magneto-polymer composite particles could find a promising application in antitumor magnetic hyperthermia. [ABSTRACT FROM AUTHOR]

Abstract: Peptide vaccines using specific antigens with poor immunogenicity like GnRH-I are unable to develop an effective adaptive immune response and require the presence of adjuvants, essential to lymphocytic activation. Three chitosan formulations were evaluated for their ability as adjuvant of a poor immunogenic peptide vaccine against GnRH-I. Male Sprague–Dawley rats were immunized subcutaneously with recombinant His-GnRH-tandem-repeat peptide in high, low and phosphorylated high molecular weight chitosan solution at 0.5% (w/v). Freund''s complete adjuvant was used as a positive control of immune response. Our results suggest that different chitosan formulations as adjuvant, with high or low viscosity degree allow inducing a high and persistent immune response against a poor immunogenic recombinant peptide. We found that the immune response was mediated by a increasing of IgG isotype 1, which were significantly greater than levels presented by the animals immunized with Freund''s complete adjuvant. Nevertheless, chitosan with low molecular weight and highest acetylation degree was able to induce an immune response mediated by IgG isotype 2a. Additionally, high molecular weight phosphorylated chitosan, in which the phosphate groups were linked to N-acetyl-d-glucosamine unit, the immune response was reduced. All the immune responses obtained with chitosan as adjuvant were able to neutralize effectively the GnRH hormone proves by reducing of animal steroidogenesis and spermatogenesis demonstrating its capacity to improve immunogenicity in peptide vaccine. [Copyright &y& Elsevier]

Abstract: This work concerns the use of different biopolymers such as chitosan, alginate or κ-carrageenan as substrates to contribute to the study of the crystallization of calcium carbonate. The experimental biomimetic approach involves the preparation of mixtures of biopolymer solutions with a solution of CaCl2, which is processed by means of spin-coating and then exposed to CO2 by a slow diffusion method for the growth of CaCO3. The obtained crystals show that each biopolymer has different effects on the crystallization habit. Different agglomerations of calcium carbonate crystals are initially the vaterite phase, which is subsequently stabilized as calcite. Biomineralization on each biopolymer gave rise to complex structures very different to those normally found in vitro, but similar to those observed in Nature. This confirms the strong influence of the macromolecules with ionizable groups on the stabilization of a determined polymorph and also on the morphology of the calcium carbonate crystals. [Copyright &y& Elsevier]

Abstract: The biopolymer chitosan was chemically modified by grafting polyacrylamide or polyacrylic acid in a homogeneous aqueous phase using potassium persulfate (KPS) as redox initiator system in the presence of -methylene-bis-acrylamide as a crosslinking agent. The influence of the grafted chitosan on calcium salts crystallization in vitro was studied using the sitting-drop method. By using polyacrylamide grafted chitosan as substrate, rosette-like CaSO4 crystals were observed. This was originated by the presence of sulfate coming from the initiator KPS. By comparing crystallization on pure chitosan and on grafted chitosan, a dramatic influence of the grafted polymer on the crystalline habit of both salts was observed. Substrates prepared by combining sulfate with chitosan or sulfate with polyacrylamide did not produce similar CaSO4 morphologies. Moreover, small spheres or donut-shaped CaCO3 crystals on polyacrylic acid grafted chitosan were generated. The particular morphology of CaCO3 crystals depends also on other synthetic parameters such as the molecular weight of the chitosan sample and the KPS concentration. [Copyright &y& Elsevier]